The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular ...

and a preventive approach combining cardio- and renal-protective drugs. It’s a strategy that improves clinicians’ chances of delaying the silent progression towards dialysis, kidney ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with ...

This improves energy metabolism in the kidney and reduces nutrient loss in the urine. These drugs also improve nutrient storage by augmenting insulin synthesis and secretion, which is glucose ...

It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal ... the overall benefit of this effect in renal protection (prevention of a rise in ...

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of Iowa has found. Tea consumption offers protective effects on mortality ...